Dynavax

-$1.69 (-8.97%) As of 3:37 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Dynavax and other ETFs, options, and stocks.

About DVAX

Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older.

CEO

Ryan Spencer

Employees

245

Headquarters

Emeryville, California

Founded

1996

DVAX Key Statistics

Market Cap

1.97B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

2.04M

High Today

$18.50

Low Today

$16.72

Open Price

$18.50

Volume

2.69M

52 Week High

$20.96

52 Week Low

$3.58

DVAX News

MarketWatchOct 18

Dynavax Shares Rise 11% Premarket on Results for Covid-19 Vaccine Candidate

By Chris Wack Dynavax Technologies Corp. shares rose 11% to $18.80 in premarket trading after the company said Valneva SE reported positive topline results fro

DVAX Earnings

-$0.53

-$0.33

-$0.14

$0.06

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Available Nov 4, After Hours